Contact Us
Make My Homepage
Merck

Merck

Merck
(Chris Hondros/Getty Images)
[

Merck to Cut 8,500 Additional Jobs

Drugmaker Merck says it plans to reduce its global workforce by another 8,500 jobs as part of a plan to cut its annual costs by about $2.5 billion by the end of 2015.

Read More|Comment

Drugs3-300x200
[

Shares of Merck, Bristol Jump on Cancer Drug News

Shares of Bristol-Myers Squibb Inc. and Merck & Co. gained about 4 percent each after the drugmakers announced encouraging results on experimental cancer medicines over the weekend.

Read More|Comment

Getty Images
Getty Images
[

FDA Panel Backs Experimental Merck Insomnia Drug

A federal panel of medical experts says that an experimental insomnia drug from Merck & Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving.

Read More|Comment

Merck-300x2251
[

Lawsuit Alleges Merck Discrimination Against Women

A Merck & Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn't give women equal opportunities for advancement and punishes employees for taking maternity leave.

Read More|Comment

Merck-300x225
[

Merck’s Ragweed Allergy Therapy Under FDA Review

Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.

Read More|Comment

Merck-300x2251
[

Merck: FDA Reviewing Tablet to Eliminate Allergy

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.

Read More|Comment

Merck-300x225
[

Merck Getting New Research and Development Director

Merck & Co. is getting a new director of research and development.

Read More|Comment

Getty Images
Getty Images
[

Merck to File For Insomnia Drug Approval

Merck & Co. said Monday it will file for U.S. marketing approval of its experimental insomnia drug suvorexant in 2012.

Read More|Comment

Category: All News Tags: ,

It appears that you already have an account created within our VIP network of sites on . To keep your points and personal information safe, we need to verify that it's really you. To activate your account, please confirm your password. When you have confirmed your password, you will be able to log in through Facebook on both sites.

Forgot your password?

*Please note that your points, prizes and activities will not be shared between programs within our VIP network.

It appears that you already have an account on this site associated with . To connect your existing account with your Facebook account, just click on the account activation button below. You will maintain your existing profile and VIP program points. After you do this, you will be able to always log in to http://nj1015.com using your Facebook account.

*Please note that your points, prizes and activities will not be shared between programs within our VIP network.

Please fill out the information below to help us provide you a better experience.

Register on New Jersey 101.5 quickly by logging in with your Facebook account. It's just as secure, and no password to remember!

Not a Member? Sign Up Here

Register on New Jersey 101.5 quickly by logging in with your Facebook account. It's just as secure, and no password to remember!